GLP-1 receptor agonists are primarily known for aiding weight loss, but emerging research indicates they may also provide significant cardiovascular and renal benefits. This article discusses the mechanisms behind these effects, highlights key clinical trials, and emphasizes the…
A new clinical trial aims to investigate whether a gradual reduction in semaglutide dosage before complete cessation can lead to better weight maintenance and cardiometabolic outc…
A recent study explored the interrelated pathways linking diet quality, functional ability, and cardiometabolic risk among adults with disabilities. Conducted in Palestine, the re…
A study from the University of Southern California reveals that a modified Mediterranean diet, low in protein and balanced in methionine, promotes healthier aging in mice while al…